Epidemiological data leaves no illusions – diabetes mellitus is a real epidemic of a non-communicable disease. Glycated haemoglobin was isolated with chromatography column as a separate subtype of haemoglobin as early as in 1958. An increase in its concentration in response to hyperglycaemia has already been recognized in 1969. Glycated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control in patients with diabetes. With HbA1C measurement we are able to retrospectively assess the average blood glucose levels. HbA1c correlates well with the risk of long-term diabetes complications. However, HbA1C levels may sometimes be misleading as a reliable measure of glycemic control. HbA1c values measurements are prone to diagnostic interference with many factors. The aim of this review was to present the numerous clinical scenarios in which the use of HbA1c levels alone for either diagnosis or as a marker of glycemic control, may lead to false assumptions.

glycated haemoglobin; HbA1C; diabetes mellitus

2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet 2019; 8, Suppl. A: A1–A94. DOI: 10.5603/DK.2019.0001

Mehta K, Chavda P (2016) Beat Diabetes: Are We Ready. Gen Med (Los Angel) 4: e108. doi:10.4172/2327-5146.1000e108

Grzybowski A: Opieka okulistyczna nad pacjentem z cukrzycą – wybrane doświadczenia międzynarodowe. Fundacja Wspierania Rozwoju Okulistyki „OKULISTYKA 21”. Poznań 2016. S. 7–79.

IDF DIABETES ATLAS Seventh Edition 2015

Huisman TH, Martis EA, Dozy A (1958). "Chromatography of hemoglobin types on carboxymethylcellulose". J. Lab. Clin. Med. 52 (2): 312–27. PMID 13564011.

Bookchin RM, Gallop PM (1968). "Structure of haemoglobin A1c: nature of the N-terminal beta chain blocking group". Biochem. Biophys. Res. Commun. 32 (1): 86–93.PMID 4874776. doi:10.1016/0006-291X(68)90430-0.

Rahbar S, Blumenfeld O, Ranney HM (1969). "Studies of an unusual hemoglobin in patients with diabetes mellitus". Biochem. Biophys. Res. Commun. 36 (5): 838–43.PMID 5808299. doi:10.1016/0006-291X(69)90685-8

Bunn HF, Haney DN, Gabbay KH, Gallop PM (1975). "Further identification of the nature and linkage of the carbohydrate in haemoglobin A1c". Biochem. Biophys. Res. Commun.67 (1): 103–9. PMID 1201013. doi:10.1016/0006-291X(75)90289-2

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennili A, Goldestein DE. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275–278. doi: 10.2337/diacare.25.2.275.

Hussain A, Ali I, Ijaz M, Rahim A. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51-57.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.

U.K. Prospective Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas of insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.

American Diabetes association STANDARDS OF MEDICAL CARE IN DIABETES—2017 , January 2017 ,Volume 40 suplement 1 S13

American Diabetes Association. Executive Summary: standard of medical care in diabetes — 2010: current criteria for the diagnosis of diabetes. Diabetes Care 2010; 33 (supl. 1): S4–S10.

2013 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular disease developed in collaboration with EASD. Eur. Heart J. 2013; 34:3035–3087.

Bianchi K., Miccoli R., Bonnadonna R.C. i wsp. Pathogenetic Mechanisms and Cardiovascular Risk Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. Diabetes Care 2012; 35: 2607–2612.

Cohen, Robert M et al. “Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c” Blood vol. 112,10 (2008): 4284-91.

Brooks AP, Metcalfe J, Day JL, Edwards MS. Iron deficiency and glycosylated haemoglobin A,. Lancet 1980;ii: 141.

Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of human hemoglobin A c. Slow glycosylation of hemoglobin in vivo. J Clin Invest 1976;57: 1652-9.

Cohen RM, Smith EP. Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin Clin Nutr Metab Care 2008;11:512–517

Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981;67: 361-9.

Ahmed, Ameena T et al. “The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry” Journal of general internal medicine vol. 23,3 (2008): 275-82

Pani, Lydie N et al. “Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.” Diabetes care vol. 31,10 (2008): 1991-6. doi:10.2337/dc08-0577

Nakashima K, Nishizaki O, Andoh Y: Acceleration of hemoglobin glycation with aging. Clin Chim Acta215:111–118, 1993

Kilpatrick ES, Dominiczak MH, Small M: The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes. Q J Med 89:307–312, 1996

Wisdom K, Fryzek JP, Havstad SL, Anderson RM, Dreiling MC, Tilley BC.Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization. Diabetes Care 1997;20:971–977

Saaddine JB, Fagot-Campagna A, Rolka D, et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002;25: 1326–1330

Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010;87:415–421

Tarim O, Kucukerdogan A, Gunay U, Eralp O, Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int. 1999;41(4):357–362.

Sluiter WJ, van Essen LH, Reitsma WD, Doorenbos H. Glikozylowana hemoglobina i niedobór żelaza. Lancet. 1980; 2 : 531-2.

Hashimoto K, Osugi T, Noguchi S, et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2009;33(3):509–511. doi:10.2337/dc09-1954

Nomura Y, et al. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res. 1989;11:177–180.

Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver diseases) -HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008;81:258–262. doi: 10.1016/j.diabres.2008.04.012

Lorenzo-Medina M, De-La-Iglesia S, Ropero P, Nogueira-Salgueiro P, Santana-Benitez J. Effects of hemoglobin variants on hemoglobin A1c values measured using a high-performance liquid chromatography method. J Diabetes Sci Technol. 2014;8:1168-1176.

U.S. Department of Health and Human Services National Institute of Diabetes and Digestive and Kidney Diseases Title: Sickle Cell Trait & Other Hemoglobinopathies & Diabetes (For Providers) Available from: https://www.niddk.nih.gov/health-information/diagnostic-tests/sickle-cell-trait-hemoglobinopathies-diabetes (accessed: 2018.11.12)

Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153–163.

Arakaki RF, Changcharoen B. Glycemic assessment in a patient with Hb Leiden and type 2 diabetes. AACE Clinical Case Rep. 2016;2:e307-e310

Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis . Intern Med 1998; 37 :826–830

Ng, Jen M et al. “The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease” Diabetes care vol. 33,11 (2010): 2310-3.

Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 1991;14:68–72.

Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes. 1992; 41: 167–173. 10.2337/diabetes.41.2.167

M.J.M. Diekman1, H.J.M. Salden , J.H. DeVries. A patient with hyperglycaemia and normal HbA1c due to impaired glycation. The Netherlands Journal of Medicine. November 2007, V ol. 65, N o. 10 p.395-397. ISSN 0300 -2977